摘要
乳腺癌对化放疗敏感,常规的综合治疗可使相当部分患者长期无病生存,但对复发和高危乳腺癌患者效果不佳。造血干细胞移植(HSCT)技术为晚期、高危乳腺癌的治疗带来了新的选择。
Breast cancer is sensitive to chemotherapy and radiotherapy. Most breast cancer patients can acquire survival benefit from the conventional regimen, but it is not satisfied for those recurrent and high-risk breast cancer patients. Hematopoietic stem cell transplantation is a new selection for recurrent and high-risk breast cancer patients.
出处
《国际肿瘤学杂志》
CAS
2006年第10期765-768,共4页
Journal of International Oncology
关键词
造血干细胞移植
乳腺肿瘤
治疗
临床研究性
Hematopoietic stem cell transplantation
Breast neoplasms
Therapies, investigational